BUSINESS● LOW1h ago · Oct 30, 2026, 1:29 AM
Dexcom anticipates $5.20B-$5.25B 2026 revenue while authorizing another $1B buyback
Seeking Alpha Tech · north america
Dexcom anticipates a revenue range of $5.20 billion to $5.25 billion for 2026. The company has also authorized an additional $1 billion share buyback.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS25m agoPennyMac outlines $160M annualized expense cuts as it expects Q4 2026 adjusted ROE to remain near current levelsSeeking Alpha TechBUSINESS25m agoSCI expects $1.10-$1.20 Q4 2026 EPS as it targets preneed momentum despite weaker funeral volumesSeeking Alpha Tech